跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
TEVA-VARENICLINE
Authorized
STANDARD
TEVA-VARENICLINE
teva canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2255d34bee9973bd
Company
teva canada limited
Type
Standard
Approval Details
Approval Id
2255d34bee9973bd
Drug Approval Canada Name
TEVA-VARENICLINE
Product Name
TEVA-VARENICLINE
Status
Dormant
Status Date
2024-05-03
Original Market Date
2019-04-23
Din
02426226
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
12:02.00
Atc Original
N07BA03 VARENICLINE
Atc Name
n 07 ba 03
Aig Number
0152190001
Company Name
teva canada limited
Company Address
30 Novopharm Court, Toronto, Ontario, Canada, M1B 2K9
Active Ingredients
VARENICLINE (VARENICLINE TARTRATE)
0.5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2255d34bee9973bd
Type
Standard
Back to Health Canada Approvals
TEVA-VARENICLINE - Health Canada Drug Approval Details